nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—ANXA4—liver cancer	0.0209	0.0382	CbGpPWpGaD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.0196	0.0357	CbGpPWpGaD
Mitotane—Gastrointestinal toxicity—Epirubicin—liver cancer	0.0172	0.0385	CcSEcCtD
Mitotane—Gastrointestinal toxicity—Doxorubicin—liver cancer	0.016	0.0356	CcSEcCtD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.0159	0.029	CbGpPWpGaD
Mitotane—CYP11B1—Endogenous sterols—NR1H4—liver cancer	0.015	0.0274	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—UGDH—liver cancer	0.0144	0.0263	CbGpPWpGaD
Mitotane—Cystitis haemorrhagic—Epirubicin—liver cancer	0.0141	0.0315	CcSEcCtD
Mitotane—Mucosal inflammation—Sorafenib—liver cancer	0.0138	0.0309	CcSEcCtD
Mitotane—Cystitis haemorrhagic—Doxorubicin—liver cancer	0.0131	0.0291	CcSEcCtD
Mitotane—CYP11A1—Endogenous sterols—NR1H4—liver cancer	0.0128	0.0235	CbGpPWpGaD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—ANXA5—liver cancer	0.012	0.0219	CbGpPWpGaD
Mitotane—Hypothyroidism—Sorafenib—liver cancer	0.0119	0.0266	CcSEcCtD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—ANXA2—liver cancer	0.011	0.0201	CbGpPWpGaD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.0107	0.0195	CbGpPWpGaD
Mitotane—Endocrine disorder—Sorafenib—liver cancer	0.00924	0.0206	CcSEcCtD
Mitotane—Proteinuria—Sorafenib—liver cancer	0.00872	0.0194	CcSEcCtD
Mitotane—Polyneuropathy—Epirubicin—liver cancer	0.00868	0.0194	CcSEcCtD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.00864	0.0158	CbGpPWpGaD
Mitotane—Protein urine present—Sorafenib—liver cancer	0.0086	0.0192	CcSEcCtD
Mitotane—FDX1—Biological oxidations—NR1H4—liver cancer	0.00842	0.0154	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—GSTA3—liver cancer	0.00828	0.0151	CbGpPWpGaD
Mitotane—Polyneuropathy—Doxorubicin—liver cancer	0.00804	0.0179	CcSEcCtD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.00765	0.014	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—GSTA4—liver cancer	0.00757	0.0138	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—GSTA2—liver cancer	0.00738	0.0135	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—GSTA1—liver cancer	0.00712	0.013	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—NAT2—liver cancer	0.00704	0.0129	CbGpPWpGaD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00697	0.0127	CbGpPWpGaD
Mitotane—Neoplasm—Sorafenib—liver cancer	0.00692	0.0154	CcSEcCtD
Mitotane—Gynaecomastia—Sorafenib—liver cancer	0.00685	0.0153	CcSEcCtD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.0062	0.0113	CbGpPWpGaD
Mitotane—SHBG—Nongenotropic Androgen signaling—RAF1—liver cancer	0.00605	0.0111	CbGpPWpGaD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00596	0.0109	CbGpPWpGaD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00565	0.0103	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—HPGDS—liver cancer	0.00563	0.0103	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.0052	0.00951	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—UGDH—liver cancer	0.00514	0.00939	CbGpPWpGaD
Mitotane—Mucosal inflammation—Epirubicin—liver cancer	0.00511	0.0114	CcSEcCtD
Mitotane—Breast disorder—Sorafenib—liver cancer	0.00502	0.0112	CcSEcCtD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00483	0.00883	CbGpPWpGaD
Mitotane—Mucosal inflammation—Doxorubicin—liver cancer	0.00473	0.0106	CcSEcCtD
Mitotane—FDX1—Biological oxidations—CYP2E1—liver cancer	0.00459	0.00839	CbGpPWpGaD
Mitotane—Myasthenia—Epirubicin—liver cancer	0.0045	0.01	CcSEcCtD
Mitotane—Neutropenia—Sorafenib—liver cancer	0.00449	0.01	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—UGDH—liver cancer	0.00439	0.00803	CbGpPWpGaD
Mitotane—Infestation—Sorafenib—liver cancer	0.00428	0.00956	CcSEcCtD
Mitotane—Infestation NOS—Sorafenib—liver cancer	0.00428	0.00956	CcSEcCtD
Mitotane—FDX1—Biological oxidations—GGT1—liver cancer	0.00421	0.0077	CbGpPWpGaD
Mitotane—Myasthenia—Doxorubicin—liver cancer	0.00417	0.00929	CcSEcCtD
Mitotane—Hepatobiliary disease—Sorafenib—liver cancer	0.00405	0.00904	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—TCF4—liver cancer	0.00389	0.00711	CbGpPWpGaD
Mitotane—Dermatitis atopic—Epirubicin—liver cancer	0.00382	0.00853	CcSEcCtD
Mitotane—Urinary tract disorder—Sorafenib—liver cancer	0.0038	0.00847	CcSEcCtD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.0038	0.00694	CbGpPWpGaD
Mitotane—Albuminuria—Epirubicin—liver cancer	0.00379	0.00846	CcSEcCtD
Mitotane—FDX1—Biological oxidations—GSTP1—liver cancer	0.00378	0.00692	CbGpPWpGaD
Mitotane—Connective tissue disorder—Sorafenib—liver cancer	0.00378	0.00843	CcSEcCtD
Mitotane—Urethral disorder—Sorafenib—liver cancer	0.00377	0.00841	CcSEcCtD
Mitotane—CYP11B1—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00375	0.00685	CbGpPWpGaD
Mitotane—Fungal infection—Epirubicin—liver cancer	0.00367	0.00818	CcSEcCtD
Mitotane—SHBG—Nongenotropic Androgen signaling—PIK3CA—liver cancer	0.0036	0.00658	CbGpPWpGaD
Mitotane—Flushing—Sorafenib—liver cancer	0.00357	0.00796	CcSEcCtD
Mitotane—Dermatitis atopic—Doxorubicin—liver cancer	0.00354	0.00789	CcSEcCtD
Mitotane—Albuminuria—Doxorubicin—liver cancer	0.00351	0.00782	CcSEcCtD
Mitotane—Angiopathy—Sorafenib—liver cancer	0.00349	0.00778	CcSEcCtD
Mitotane—FDX1—Biological oxidations—GSTM1—liver cancer	0.00348	0.00636	CbGpPWpGaD
Mitotane—Fungal infection—Doxorubicin—liver cancer	0.00339	0.00757	CcSEcCtD
Mitotane—Mental disorder—Sorafenib—liver cancer	0.00337	0.00752	CcSEcCtD
Mitotane—Liver injury—Epirubicin—liver cancer	0.00336	0.0075	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00335	0.00613	CbGpPWpGaD
Mitotane—Malnutrition—Sorafenib—liver cancer	0.00335	0.00747	CcSEcCtD
Mitotane—SHBG—Nongenotropic Androgen signaling—HRAS—liver cancer	0.00333	0.00609	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—TCF4—liver cancer	0.00333	0.00608	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—CYP1A1—liver cancer	0.0033	0.00602	CbGpPWpGaD
Mitotane—Dysgeusia—Sorafenib—liver cancer	0.00328	0.00731	CcSEcCtD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.00325	0.00594	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00323	0.00591	CbGpPWpGaD
Mitotane—CYP11A1—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.0032	0.00586	CbGpPWpGaD
Mitotane—Liver injury—Doxorubicin—liver cancer	0.00311	0.00694	CcSEcCtD
Mitotane—Anaemia—Sorafenib—liver cancer	0.00309	0.0069	CcSEcCtD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.00308	0.00562	CbGpPWpGaD
Mitotane—Dyskinesia—Epirubicin—liver cancer	0.00301	0.00672	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—NR1H4—liver cancer	0.003	0.00548	CbGpPWpGaD
Mitotane—Dysarthria—Epirubicin—liver cancer	0.00299	0.00667	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—GSTA3—liver cancer	0.00295	0.00539	CbGpPWpGaD
Mitotane—SHBG—Nongenotropic Androgen signaling—AKT1—liver cancer	0.00294	0.00537	CbGpPWpGaD
Mitotane—Econazole—CYP2E1—liver cancer	0.00292	0.633	CrCbGaD
Mitotane—CYP11B1—Metapathway biotransformation—GSTA3—liver cancer	0.00291	0.00532	CbGpPWpGaD
Mitotane—Hypertension—Sorafenib—liver cancer	0.00289	0.00645	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00283	0.00631	CcSEcCtD
Mitotane—Hepatocellular injury—Epirubicin—liver cancer	0.00283	0.00631	CcSEcCtD
Mitotane—Dyskinesia—Doxorubicin—liver cancer	0.00279	0.00622	CcSEcCtD
Mitotane—Dysarthria—Doxorubicin—liver cancer	0.00277	0.00618	CcSEcCtD
Mitotane—Salivary hypersecretion—Epirubicin—liver cancer	0.00275	0.00613	CcSEcCtD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.00273	0.00498	CbGpPWpGaD
Mitotane—Infection—Sorafenib—liver cancer	0.00271	0.00605	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—GSTA4—liver cancer	0.0027	0.00493	CbGpPWpGaD
Mitotane—CYP11B1—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.00269	0.00492	CbGpPWpGaD
Mitotane—Shock—Sorafenib—liver cancer	0.00269	0.006	CcSEcCtD
Mitotane—Nervous system disorder—Sorafenib—liver cancer	0.00268	0.00598	CcSEcCtD
Mitotane—Thrombocytopenia—Sorafenib—liver cancer	0.00268	0.00597	CcSEcCtD
Mitotane—CYP11B1—Metapathway biotransformation—GSTA4—liver cancer	0.00266	0.00486	CbGpPWpGaD
Mitotane—Skin disorder—Sorafenib—liver cancer	0.00265	0.00592	CcSEcCtD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.00263	0.00481	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—GSTA2—liver cancer	0.00263	0.00481	CbGpPWpGaD
Mitotane—Hepatocellular injury—Doxorubicin—liver cancer	0.00262	0.00584	CcSEcCtD
Mitotane—Anorexia—Sorafenib—liver cancer	0.0026	0.00581	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—NR1H4—liver cancer	0.00257	0.00469	CbGpPWpGaD
Mitotane—Neoplasm—Epirubicin—liver cancer	0.00256	0.00571	CcSEcCtD
Mitotane—Salivary hypersecretion—Doxorubicin—liver cancer	0.00254	0.00567	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—GSTA1—liver cancer	0.00254	0.00464	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—GSTA3—liver cancer	0.00252	0.00461	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—NAT2—liver cancer	0.00251	0.00458	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—GSTA3—liver cancer	0.00249	0.00455	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—NAT2—liver cancer	0.00247	0.00452	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.00247	0.00452	CbGpPWpGaD
Mitotane—FDX1—Metabolism—UGDH—liver cancer	0.00246	0.00451	CbGpPWpGaD
Mitotane—Mental disability—Epirubicin—liver cancer	0.00246	0.00548	CcSEcCtD
Mitotane—Dyspepsia—Sorafenib—liver cancer	0.00241	0.00537	CcSEcCtD
Mitotane—Decreased appetite—Sorafenib—liver cancer	0.00238	0.0053	CcSEcCtD
Mitotane—Neoplasm—Doxorubicin—liver cancer	0.00237	0.00528	CcSEcCtD
Mitotane—Gastrointestinal disorder—Sorafenib—liver cancer	0.00236	0.00526	CcSEcCtD
Mitotane—Pain—Sorafenib—liver cancer	0.00234	0.00521	CcSEcCtD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.00233	0.00426	CbGpPWpGaD
Mitotane—FDX1—Metabolism—EPT1—liver cancer	0.00232	0.00424	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—GSTA4—liver cancer	0.00231	0.00422	CbGpPWpGaD
Mitotane—CYP11A1—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.0023	0.00421	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—GSTA4—liver cancer	0.00228	0.00416	CbGpPWpGaD
Mitotane—Mental disability—Doxorubicin—liver cancer	0.00227	0.00507	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—GSTA2—liver cancer	0.00225	0.00411	CbGpPWpGaD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00221	0.00404	CbGpPWpGaD
Mitotane—FDX1—Metabolism—TAT—liver cancer	0.0022	0.00402	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—GSTA1—liver cancer	0.00217	0.00397	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.00216	0.00395	CbGpPWpGaD
Mitotane—Body temperature increased—Sorafenib—liver cancer	0.00216	0.00482	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—NAT2—liver cancer	0.00215	0.00392	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—NAT2—liver cancer	0.00212	0.00387	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—GPX3—liver cancer	0.0021	0.00384	CbGpPWpGaD
Mitotane—Lethargy—Epirubicin—liver cancer	0.0021	0.00468	CcSEcCtD
Mitotane—Diplopia—Epirubicin—liver cancer	0.00205	0.00458	CcSEcCtD
Mitotane—Osteoarthritis—Epirubicin—liver cancer	0.00205	0.00458	CcSEcCtD
Mitotane—Hypersensitivity—Sorafenib—liver cancer	0.00201	0.00449	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—HPGDS—liver cancer	0.002	0.00366	CbGpPWpGaD
Mitotane—Asthenia—Sorafenib—liver cancer	0.00196	0.00437	CcSEcCtD
Mitotane—Lethargy—Doxorubicin—liver cancer	0.00194	0.00433	CcSEcCtD
Mitotane—Ataxia—Epirubicin—liver cancer	0.00193	0.00431	CcSEcCtD
Mitotane—Diplopia—Doxorubicin—liver cancer	0.0019	0.00424	CcSEcCtD
Mitotane—Osteoarthritis—Doxorubicin—liver cancer	0.0019	0.00424	CcSEcCtD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00189	0.00346	CbGpPWpGaD
Mitotane—Orthostatic hypotension—Epirubicin—liver cancer	0.00188	0.00419	CcSEcCtD
Mitotane—Diarrhoea—Sorafenib—liver cancer	0.00187	0.00417	CcSEcCtD
Mitotane—Breast disorder—Epirubicin—liver cancer	0.00186	0.00414	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00185	0.00339	CbGpPWpGaD
Mitotane—Muscular weakness—Epirubicin—liver cancer	0.00181	0.00404	CcSEcCtD
Mitotane—Dizziness—Sorafenib—liver cancer	0.00181	0.00403	CcSEcCtD
Mitotane—CYP11A1—Metapathway biotransformation—GPX3—liver cancer	0.0018	0.00329	CbGpPWpGaD
Mitotane—Ataxia—Doxorubicin—liver cancer	0.00179	0.00399	CcSEcCtD
Mitotane—Vomiting—Sorafenib—liver cancer	0.00174	0.00388	CcSEcCtD
Mitotane—Orthostatic hypotension—Doxorubicin—liver cancer	0.00174	0.00387	CcSEcCtD
Mitotane—Rash—Sorafenib—liver cancer	0.00172	0.00384	CcSEcCtD
Mitotane—Dermatitis—Sorafenib—liver cancer	0.00172	0.00384	CcSEcCtD
Mitotane—Breast disorder—Doxorubicin—liver cancer	0.00172	0.00383	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—HPGDS—liver cancer	0.00172	0.00314	CbGpPWpGaD
Mitotane—Headache—Sorafenib—liver cancer	0.00171	0.00382	CcSEcCtD
Mitotane—Carbinoxamine—CYP2E1—liver cancer	0.00169	0.367	CrCbGaD
Mitotane—Muscular weakness—Doxorubicin—liver cancer	0.00168	0.00374	CcSEcCtD
Mitotane—Neutropenia—Epirubicin—liver cancer	0.00166	0.0037	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—MAPK14—liver cancer	0.00164	0.00299	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—CYP2E1—liver cancer	0.00163	0.00299	CbGpPWpGaD
Mitotane—Nausea—Sorafenib—liver cancer	0.00162	0.00362	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.00162	0.00296	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—CYP2E1—liver cancer	0.00161	0.00295	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00159	0.0029	CbGpPWpGaD
Mitotane—Drowsiness—Epirubicin—liver cancer	0.00158	0.00353	CcSEcCtD
Mitotane—Infestation—Epirubicin—liver cancer	0.00158	0.00353	CcSEcCtD
Mitotane—Infestation NOS—Epirubicin—liver cancer	0.00158	0.00353	CcSEcCtD
Mitotane—Neutropenia—Doxorubicin—liver cancer	0.00154	0.00343	CcSEcCtD
Mitotane—Haematuria—Epirubicin—liver cancer	0.00151	0.00337	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—GGT1—liver cancer	0.0015	0.00274	CbGpPWpGaD
Mitotane—Hepatobiliary disease—Epirubicin—liver cancer	0.0015	0.00334	CcSEcCtD
Mitotane—FDX1—Metabolism—GLUL—liver cancer	0.00149	0.00273	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CPT1B—liver cancer	0.00149	0.00273	CbGpPWpGaD
Mitotane—Drowsiness—Doxorubicin—liver cancer	0.00147	0.00327	CcSEcCtD
Mitotane—Infestation NOS—Doxorubicin—liver cancer	0.00147	0.00327	CcSEcCtD
Mitotane—Infestation—Doxorubicin—liver cancer	0.00147	0.00327	CcSEcCtD
Mitotane—FDX1—Metabolism—NR1H4—liver cancer	0.00144	0.00263	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—BRAF—liver cancer	0.00143	0.00261	CbGpPWpGaD
Mitotane—Hepatitis—Epirubicin—liver cancer	0.00142	0.00317	CcSEcCtD
Mitotane—FDX1—Metabolism—GSTA3—liver cancer	0.00142	0.00259	CbGpPWpGaD
Mitotane—Urinary tract disorder—Epirubicin—liver cancer	0.0014	0.00313	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—MAPK14—liver cancer	0.0014	0.00256	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—CYP2E1—liver cancer	0.0014	0.00256	CbGpPWpGaD
Mitotane—Haematuria—Doxorubicin—liver cancer	0.0014	0.00312	CcSEcCtD
Mitotane—Connective tissue disorder—Epirubicin—liver cancer	0.0014	0.00312	CcSEcCtD
Mitotane—Urethral disorder—Epirubicin—liver cancer	0.00139	0.00311	CcSEcCtD
Mitotane—Hepatobiliary disease—Doxorubicin—liver cancer	0.00139	0.00309	CcSEcCtD
Mitotane—CYP11A1—Metapathway biotransformation—CYP2E1—liver cancer	0.00138	0.00252	CbGpPWpGaD
Mitotane—Visual impairment—Epirubicin—liver cancer	0.00137	0.00306	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—GSTP1—liver cancer	0.00135	0.00246	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—GSTP1—liver cancer	0.00133	0.00243	CbGpPWpGaD
Mitotane—Eye disorder—Epirubicin—liver cancer	0.00133	0.00296	CcSEcCtD
Mitotane—Flushing—Epirubicin—liver cancer	0.00132	0.00294	CcSEcCtD
Mitotane—Hepatitis—Doxorubicin—liver cancer	0.00132	0.00293	CcSEcCtD
Mitotane—Urinary tract disorder—Doxorubicin—liver cancer	0.0013	0.0029	CcSEcCtD
Mitotane—FDX1—Metabolism—GSTA4—liver cancer	0.00129	0.00237	CbGpPWpGaD
Mitotane—Connective tissue disorder—Doxorubicin—liver cancer	0.00129	0.00288	CcSEcCtD
Mitotane—Angiopathy—Epirubicin—liver cancer	0.00129	0.00288	CcSEcCtD
Mitotane—Urethral disorder—Doxorubicin—liver cancer	0.00129	0.00288	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—GGT1—liver cancer	0.00128	0.00235	CbGpPWpGaD
Mitotane—Visual impairment—Doxorubicin—liver cancer	0.00127	0.00283	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.00127	0.00231	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GSTA2—liver cancer	0.00126	0.00231	CbGpPWpGaD
Mitotane—Mental disorder—Epirubicin—liver cancer	0.00125	0.00278	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—GSTM1—liver cancer	0.00124	0.00226	CbGpPWpGaD
Mitotane—Malnutrition—Epirubicin—liver cancer	0.00124	0.00276	CcSEcCtD
Mitotane—Eye disorder—Doxorubicin—liver cancer	0.00123	0.00274	CcSEcCtD
Mitotane—CYP11B1—Metapathway biotransformation—GSTM1—liver cancer	0.00122	0.00223	CbGpPWpGaD
Mitotane—Flushing—Doxorubicin—liver cancer	0.00122	0.00272	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—BRAF—liver cancer	0.00122	0.00223	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GSTA1—liver cancer	0.00122	0.00223	CbGpPWpGaD
Mitotane—Dysgeusia—Epirubicin—liver cancer	0.00121	0.0027	CcSEcCtD
Mitotane—FDX1—Metabolism—NAT2—liver cancer	0.0012	0.0022	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00119	0.00218	CbGpPWpGaD
Mitotane—Angiopathy—Doxorubicin—liver cancer	0.00119	0.00266	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—RAF1—liver cancer	0.00119	0.00218	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—CYP1A1—liver cancer	0.00117	0.00215	CbGpPWpGaD
Mitotane—Vision blurred—Epirubicin—liver cancer	0.00117	0.0026	CcSEcCtD
Mitotane—CYP11B1—Metapathway biotransformation—CYP1A1—liver cancer	0.00116	0.00212	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.00116	0.00212	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ALDOB—liver cancer	0.00115	0.00211	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—GSTP1—liver cancer	0.00115	0.00211	CbGpPWpGaD
Mitotane—Mental disorder—Doxorubicin—liver cancer	0.00115	0.00257	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00115	0.00211	CbGpPWpGaD
Mitotane—Malnutrition—Doxorubicin—liver cancer	0.00114	0.00255	CcSEcCtD
Mitotane—Anaemia—Epirubicin—liver cancer	0.00114	0.00255	CcSEcCtD
Mitotane—CYP11A1—Metapathway biotransformation—GSTP1—liver cancer	0.00114	0.00208	CbGpPWpGaD
Mitotane—Dysgeusia—Doxorubicin—liver cancer	0.00112	0.0025	CcSEcCtD
Mitotane—Vertigo—Epirubicin—liver cancer	0.00111	0.00248	CcSEcCtD
Mitotane—FDX1—Metabolism—CRABP1—liver cancer	0.0011	0.00201	CbGpPWpGaD
Mitotane—Vision blurred—Doxorubicin—liver cancer	0.00108	0.00241	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—CASP3—liver cancer	0.00107	0.00195	CbGpPWpGaD
Mitotane—Hypertension—Epirubicin—liver cancer	0.00107	0.00238	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—IL2—liver cancer	0.00107	0.00195	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—GSTM1—liver cancer	0.00106	0.00194	CbGpPWpGaD
Mitotane—Anaemia—Doxorubicin—liver cancer	0.00106	0.00236	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00105	0.00233	CcSEcCtD
Mitotane—CYP11A1—Metapathway biotransformation—GSTM1—liver cancer	0.00105	0.00191	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—CTNNB1—liver cancer	0.00103	0.00188	CbGpPWpGaD
Mitotane—Vertigo—Doxorubicin—liver cancer	0.00103	0.00229	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00102	0.00187	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—RAF1—liver cancer	0.00102	0.00186	CbGpPWpGaD
Mitotane—Confusional state—Epirubicin—liver cancer	0.00102	0.00227	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—CYP1A1—liver cancer	0.001	0.00184	CbGpPWpGaD
Mitotane—Infection—Epirubicin—liver cancer	0.001	0.00224	CcSEcCtD
Mitotane—Shock—Epirubicin—liver cancer	0.000994	0.00222	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000991	0.00181	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—CYP1A1—liver cancer	0.000991	0.00181	CbGpPWpGaD
Mitotane—Nervous system disorder—Epirubicin—liver cancer	0.00099	0.00221	CcSEcCtD
Mitotane—Thrombocytopenia—Epirubicin—liver cancer	0.000989	0.00221	CcSEcCtD
Mitotane—Hypertension—Doxorubicin—liver cancer	0.000988	0.0022	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000986	0.0018	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—MAPK8—liver cancer	0.000983	0.0018	CbGpPWpGaD
Mitotane—Skin disorder—Epirubicin—liver cancer	0.000981	0.00219	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000968	0.00216	CcSEcCtD
Mitotane—Anorexia—Epirubicin—liver cancer	0.000963	0.00215	CcSEcCtD
Mitotane—FDX1—Metabolism—HPGDS—liver cancer	0.000962	0.00176	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000957	0.00175	CbGpPWpGaD
Mitotane—Hypotension—Epirubicin—liver cancer	0.000944	0.0021	CcSEcCtD
Mitotane—Confusional state—Doxorubicin—liver cancer	0.000942	0.0021	CcSEcCtD
Mitotane—Infection—Doxorubicin—liver cancer	0.000928	0.00207	CcSEcCtD
Mitotane—Shock—Doxorubicin—liver cancer	0.000919	0.00205	CcSEcCtD
Mitotane—Nervous system disorder—Doxorubicin—liver cancer	0.000916	0.00204	CcSEcCtD
Mitotane—Thrombocytopenia—Doxorubicin—liver cancer	0.000915	0.00204	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—CASP3—liver cancer	0.000915	0.00167	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—IL2—liver cancer	0.000913	0.00167	CbGpPWpGaD
Mitotane—Skin disorder—Doxorubicin—liver cancer	0.000908	0.00202	CcSEcCtD
Mitotane—Paraesthesia—Epirubicin—liver cancer	0.000907	0.00202	CcSEcCtD
Mitotane—Somnolence—Epirubicin—liver cancer	0.000898	0.002	CcSEcCtD
Mitotane—Anorexia—Doxorubicin—liver cancer	0.000891	0.00199	CcSEcCtD
Mitotane—Dyspepsia—Epirubicin—liver cancer	0.000889	0.00198	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—CTNNB1—liver cancer	0.000882	0.00161	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000881	0.00161	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—UGDH—liver cancer	0.000878	0.00161	CbGpPWpGaD
Mitotane—Decreased appetite—Epirubicin—liver cancer	0.000878	0.00196	CcSEcCtD
Mitotane—Hypotension—Doxorubicin—liver cancer	0.000873	0.00195	CcSEcCtD
Mitotane—Gastrointestinal disorder—Epirubicin—liver cancer	0.000872	0.00194	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000871	0.00159	CbGpPWpGaD
Mitotane—Pain—Epirubicin—liver cancer	0.000864	0.00193	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.00086	0.00157	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PSMD10—liver cancer	0.000858	0.00157	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PSMA4—liver cancer	0.000858	0.00157	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—MAPK8—liver cancer	0.000841	0.00154	CbGpPWpGaD
Mitotane—Paraesthesia—Doxorubicin—liver cancer	0.000839	0.00187	CcSEcCtD
Mitotane—FDX1—Metabolism—GOT2—liver cancer	0.000834	0.00153	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—TGFB1—liver cancer	0.000833	0.00152	CbGpPWpGaD
Mitotane—Feeling abnormal—Epirubicin—liver cancer	0.000832	0.00186	CcSEcCtD
Mitotane—Somnolence—Doxorubicin—liver cancer	0.000831	0.00185	CcSEcCtD
Mitotane—CYP11B1—Metabolism—EPT1—liver cancer	0.000826	0.00151	CbGpPWpGaD
Mitotane—Dyspepsia—Doxorubicin—liver cancer	0.000823	0.00183	CcSEcCtD
Mitotane—Decreased appetite—Doxorubicin—liver cancer	0.000812	0.00181	CcSEcCtD
Mitotane—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000807	0.0018	CcSEcCtD
Mitotane—Pain—Doxorubicin—liver cancer	0.000799	0.00178	CcSEcCtD
Mitotane—Body temperature increased—Epirubicin—liver cancer	0.000798	0.00178	CcSEcCtD
Mitotane—FDX1—Metabolism—CYP2E1—liver cancer	0.000785	0.00143	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—TAT—liver cancer	0.000783	0.00143	CbGpPWpGaD
Mitotane—Feeling abnormal—Doxorubicin—liver cancer	0.00077	0.00172	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.00077	0.00141	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.00076	0.00139	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000753	0.00138	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—UGDH—liver cancer	0.000751	0.00137	CbGpPWpGaD
Mitotane—Hypersensitivity—Epirubicin—liver cancer	0.000744	0.00166	CcSEcCtD
Mitotane—Body temperature increased—Doxorubicin—liver cancer	0.000739	0.00165	CcSEcCtD
Mitotane—FDX1—Metabolism—CYCS—liver cancer	0.000734	0.00134	CbGpPWpGaD
Mitotane—Asthenia—Epirubicin—liver cancer	0.000725	0.00162	CcSEcCtD
Mitotane—FDX1—Metabolism—GGT1—liver cancer	0.00072	0.00132	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GOT1—liver cancer	0.00072	0.00132	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—TGFB1—liver cancer	0.000712	0.0013	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—EPT1—liver cancer	0.000706	0.00129	CbGpPWpGaD
Mitotane—Diarrhoea—Epirubicin—liver cancer	0.000691	0.00154	CcSEcCtD
Mitotane—Hypersensitivity—Doxorubicin—liver cancer	0.000688	0.00154	CcSEcCtD
Mitotane—Asthenia—Doxorubicin—liver cancer	0.00067	0.0015	CcSEcCtD
Mitotane—CYP11A1—Metabolism—TAT—liver cancer	0.00067	0.00122	CbGpPWpGaD
Mitotane—Dizziness—Epirubicin—liver cancer	0.000668	0.00149	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000659	0.0012	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GSTP1—liver cancer	0.000647	0.00118	CbGpPWpGaD
Mitotane—Vomiting—Epirubicin—liver cancer	0.000642	0.00143	CcSEcCtD
Mitotane—Diarrhoea—Doxorubicin—liver cancer	0.000639	0.00143	CcSEcCtD
Mitotane—FDX1—Metabolism—HMOX1—liver cancer	0.000638	0.00117	CbGpPWpGaD
Mitotane—Rash—Epirubicin—liver cancer	0.000637	0.00142	CcSEcCtD
Mitotane—Dermatitis—Epirubicin—liver cancer	0.000636	0.00142	CcSEcCtD
Mitotane—Headache—Epirubicin—liver cancer	0.000633	0.00141	CcSEcCtD
Mitotane—Dizziness—Doxorubicin—liver cancer	0.000618	0.00138	CcSEcCtD
Mitotane—Nausea—Epirubicin—liver cancer	0.0006	0.00134	CcSEcCtD
Mitotane—FDX1—Metabolism—GSTM1—liver cancer	0.000595	0.00109	CbGpPWpGaD
Mitotane—Vomiting—Doxorubicin—liver cancer	0.000594	0.00133	CcSEcCtD
Mitotane—Rash—Doxorubicin—liver cancer	0.000589	0.00131	CcSEcCtD
Mitotane—Dermatitis—Doxorubicin—liver cancer	0.000589	0.00131	CcSEcCtD
Mitotane—Headache—Doxorubicin—liver cancer	0.000585	0.00131	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—AKT1—liver cancer	0.000579	0.00106	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000576	0.00105	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CYP1A1—liver cancer	0.000564	0.00103	CbGpPWpGaD
Mitotane—Nausea—Doxorubicin—liver cancer	0.000555	0.00124	CcSEcCtD
Mitotane—CYP11B1—Metabolism—GLUL—liver cancer	0.000532	0.000973	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CPT1B—liver cancer	0.000532	0.000973	CbGpPWpGaD
Mitotane—FDX1—Metabolism—MTHFR—liver cancer	0.000525	0.000961	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PPARA—liver cancer	0.000515	0.000942	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NR1H4—liver cancer	0.000513	0.000938	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTA3—liver cancer	0.000504	0.000922	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—AKT1—liver cancer	0.000495	0.000905	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000493	0.000901	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000463	0.000846	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTA4—liver cancer	0.000461	0.000843	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CPT1B—liver cancer	0.000455	0.000832	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GLUL—liver cancer	0.000455	0.000832	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000451	0.000824	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTA2—liver cancer	0.00045	0.000822	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PIK3CG—liver cancer	0.000441	0.000807	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NR1H4—liver cancer	0.000439	0.000802	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTA1—liver cancer	0.000434	0.000793	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTA3—liver cancer	0.000431	0.000789	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NAT2—liver cancer	0.000429	0.000784	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PPARG—liver cancer	0.000426	0.000779	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000412	0.000754	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ALDOB—liver cancer	0.000411	0.000752	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTA4—liver cancer	0.000395	0.000721	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CRABP1—liver cancer	0.000392	0.000717	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PIK3CD—liver cancer	0.000388	0.000709	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000386	0.000705	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTA2—liver cancer	0.000385	0.000703	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ALB—liver cancer	0.000383	0.0007	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTA1—liver cancer	0.000371	0.000678	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NAT2—liver cancer	0.000367	0.000671	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000353	0.000646	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000353	0.000645	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ALDOB—liver cancer	0.000352	0.000643	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HPGDS—liver cancer	0.000343	0.000627	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000341	0.000623	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PIK3CB—liver cancer	0.000338	0.000618	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CRABP1—liver cancer	0.000336	0.000613	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.00031	0.000568	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000306	0.00056	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PSMA4—liver cancer	0.000306	0.000559	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PSMD10—liver cancer	0.000306	0.000559	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000302	0.000552	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GOT2—liver cancer	0.000297	0.000543	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HPGDS—liver cancer	0.000293	0.000536	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000292	0.000533	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP2E1—liver cancer	0.000279	0.000511	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000271	0.000495	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000266	0.000486	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000262	0.000479	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYCS—liver cancer	0.000262	0.000478	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PSMA4—liver cancer	0.000261	0.000478	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PSMD10—liver cancer	0.000261	0.000478	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GGT1—liver cancer	0.000257	0.000469	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GOT1—liver cancer	0.000257	0.000469	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GOT2—liver cancer	0.000254	0.000465	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP2E1—liver cancer	0.000239	0.000437	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000232	0.000423	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTP1—liver cancer	0.00023	0.000421	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HMOX1—liver cancer	0.000227	0.000416	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYCS—liver cancer	0.000224	0.000409	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GGT1—liver cancer	0.00022	0.000401	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GOT1—liver cancer	0.00022	0.000401	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTM1—liver cancer	0.000212	0.000387	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PIK3CA—liver cancer	0.000206	0.000377	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP1A1—liver cancer	0.000201	0.000367	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTP1—liver cancer	0.000197	0.00036	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HMOX1—liver cancer	0.000194	0.000355	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—MTHFR—liver cancer	0.000187	0.000342	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PPARA—liver cancer	0.000184	0.000336	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTM1—liver cancer	0.000181	0.000331	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP1A1—liver cancer	0.000172	0.000314	CbGpPWpGaD
Mitotane—FDX1—Metabolism—AKT1—liver cancer	0.000168	0.000308	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000165	0.000302	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—MTHFR—liver cancer	0.00016	0.000293	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CG—liver cancer	0.000157	0.000288	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PPARA—liver cancer	0.000157	0.000287	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PPARG—liver cancer	0.000152	0.000277	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000141	0.000258	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CD—liver cancer	0.000138	0.000253	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ALB—liver cancer	0.000136	0.00025	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CG—liver cancer	0.000135	0.000246	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PPARG—liver cancer	0.00013	0.000237	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CB—liver cancer	0.000121	0.00022	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CD—liver cancer	0.000118	0.000216	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ALB—liver cancer	0.000117	0.000213	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CB—liver cancer	0.000103	0.000188	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CA—liver cancer	7.35e-05	0.000134	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CA—liver cancer	6.29e-05	0.000115	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—AKT1—liver cancer	6e-05	0.00011	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—AKT1—liver cancer	5.13e-05	9.39e-05	CbGpPWpGaD
